| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/18/1999 | US5904936 Particles based on polyamino acid(s) and capable of being used as delivery vehicles for active principle(s) and method for preparing them |
| 05/18/1999 | US5904935 Delivery of drugs with peptides and proteins |
| 05/18/1999 | US5904933 Stable reverse and multiple fluorocarbon emulsions |
| 05/18/1999 | US5904932 Topical preparation containing a suspension of solid lipid particles |
| 05/18/1999 | US5904931 Transdermal therapeutic systems that contain sex steroids and dimethyl isosorbide |
| 05/18/1999 | US5904930 Hydroxytamoxifen derivatives in solutions |
| 05/18/1999 | US5904929 Acylated cyclodextrin-containing pharmaceutical composition |
| 05/18/1999 | CA2146938C Method of controlling structure stability of collagen fibers produced from solutions or dispersions treated with sodium hydroxide for infectious agent deactivation |
| 05/18/1999 | CA2140639C Iodine/resin disinfectant and a procedure for the preparation thereof |
| 05/14/1999 | WO1999023237A1 Transfecting peptide vector, composition containing same and applications |
| 05/14/1999 | WO1999022775A1 Methods for treating prostate tumors using radioactive compositions |
| 05/14/1999 | WO1999022774A1 Radioactive embolizing compositions |
| 05/14/1999 | WO1999022770A1 Delivery of poly(ethylene glycol)-conjugated molecules from degradable hydrogels |
| 05/14/1999 | WO1999022769A1 Gellan gum tablet coating |
| 05/14/1999 | WO1999022768A1 Controlled release compositions comprising gellan gum gels |
| 05/14/1999 | WO1999022767A1 Agglomerate of spherical polyvalent-metal alginate particulates, controlled-release preparation comprising difficultly soluble drug supported on said agglomerate, and processes for producing the both |
| 05/14/1999 | WO1999022761A1 Conjugate heat shock protein-binding peptides |
| 05/14/1999 | WO1999022747A1 Bonding of cartilaginous matrices using isolated chondrocytes |
| 05/14/1999 | WO1999022741A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/14/1999 | WO1999022738A1 Compositions of lipid lowering agents |
| 05/14/1999 | WO1999022724A2 Extended release formulation containing venlafaxin |
| 05/14/1999 | WO1999022717A1 Novel formulation for use in pain management |
| 05/14/1999 | WO1999022716A1 Topical compositions for nsai drug delivery |
| 05/14/1999 | WO1999022715A1 Sustained release eyedrops |
| 05/14/1999 | WO1999022714A1 Topical compositions for prostaglandin e1 delivery |
| 05/14/1999 | WO1999022713A1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 05/14/1999 | WO1999013862A3 A pharmaceutical composition for treating dysmenorrhea and premature labor |
| 05/14/1999 | WO1999001764A3 METHOD FOR DETERMINING GnRH RECEPTORS |
| 05/14/1999 | WO1998057625A3 Composition for controlling oxidation-reduction |
| 05/14/1999 | CA2309165A1 Topical compositions for prostaglandin e1 delivery |
| 05/14/1999 | CA2309122A1 Novel formulation for use in pain management |
| 05/14/1999 | CA2308385A1 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 05/14/1999 | CA2308299A1 Conjugate heat shock protein-binding peptides |
| 05/14/1999 | CA2308291A1 Controlled release compositions comprising gellan gum gels |
| 05/14/1999 | CA2307887A1 Gellan gum tablet coating |
| 05/14/1999 | CA2307743A1 Bonding of cartilaginous matrices using isolated chondrocytes |
| 05/14/1999 | CA2307191A1 Radioactive embolizing compositions |
| 05/14/1999 | CA2307190A1 Methods for treating prostate tumors using radioactive compositions |
| 05/14/1999 | CA2307097A1 Compositions of lipid lowering agents |
| 05/14/1999 | CA2305242A1 Extended release formulation |
| 05/14/1999 | CA2302379A1 Sustained release ophthalmic compositions containing water soluble medicaments |
| 05/14/1999 | CA2276436A1 Agglomerate of spherical polyvalent-metal alginate particulates, controlled-release preparation comprising difficultly soluble drug supported on said agglomerate, and processes for producing the both |
| 05/14/1999 | CA2221195A1 Biodegradable polymer matrix |
| 05/12/1999 | EP0914832A1 Therapeutic material for periodontosis |
| 05/12/1999 | EP0914818A1 Intraorally rapidly disintegrable tablet |
| 05/12/1999 | EP0914460A1 Vehicle for the transport of molecular substances |
| 05/12/1999 | EP0914431A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 05/12/1999 | EP0914348A1 Polymers for delivering nitric oxide in vivo |
| 05/12/1999 | EP0914347A2 A multivalent major histocompatibility complex peptide fusion protein for modulating specific t cell function |
| 05/12/1999 | EP0914339A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH |
| 05/12/1999 | EP0914202A1 Preservation by foam formation |
| 05/12/1999 | EP0914168A1 New medicaments containing gelatin cross-linked with oxidized polysaccharides |
| 05/12/1999 | EP0914166A1 Methods of terminal sterilization of biological products |
| 05/12/1999 | EP0914162A2 USE OF OLIGOSACCHARIDES FOR NEUTRALISING $i(E. COLI) TOXINS |
| 05/12/1999 | EP0914161A2 Chitosan - related compositions and methods for delivery of nucleic acids into a cell |
| 05/12/1999 | EP0914160A2 Hydrophobic carbomer complex compositions |
| 05/12/1999 | EP0914159A1 Topical phospholipid-containing acyclovir preparation |
| 05/12/1999 | EP0914143A1 Medicinal cyclosporin-a aerosol solution formulation |
| 05/12/1999 | EP0914141A1 Stabilized antihepatitis-b vaccine tablets |
| 05/12/1999 | EP0914138A1 Complex preparations characterised by a betain content |
| 05/12/1999 | EP0914127A2 Antifungal composition with enhanced bioavailability |
| 05/12/1999 | EP0914126A1 Sustained release sufentanil compositions |
| 05/12/1999 | EP0914123A1 Prodrugs of thalidomide and methods for using same as modulators of t-cell function |
| 05/12/1999 | EP0914119A2 Solid oral dosage forms of valsartan |
| 05/12/1999 | EP0914116A1 Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere |
| 05/12/1999 | EP0914106A1 Pharmaceutical products containing a complex of an amide-type local anesthetic and a polyacrylate |
| 05/12/1999 | EP0914102A1 Compositions and methods for treating or preventing diseases of body passageways |
| 05/12/1999 | EP0914099A1 Oral coated active drugs |
| 05/12/1999 | EP0914098A1 Multi-layered osmotic device |
| 05/12/1999 | EP0914096A1 Microparticles and their use in wound therapy |
| 05/12/1999 | EP0914094A1 Materials and methods for making improved liposome compositions |
| 05/12/1999 | EP0914087A1 Use of fats to replace silicone in the production of cosmetic and/or pharmaceutical preparations |
| 05/12/1999 | EP0914043A1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 05/12/1999 | EP0914042A1 Cluster clearing agents |
| 05/12/1999 | EP0914040A1 Antimicrobial composition and methods of use therefor |
| 05/12/1999 | EP0810975B1 Method of producing hydrophilic or partially hydrophilic inorganic aerogels |
| 05/12/1999 | EP0789559B1 Pharmaceutical composition containing a fusible carrier and method for producing the same |
| 05/12/1999 | EP0733067B1 N-terminally chemically modified protein compositions and methods |
| 05/12/1999 | EP0722313B1 Viscoelastic compositions of fluorinated organic compounds |
| 05/12/1999 | EP0714283B1 Personal cleansing compositions |
| 05/12/1999 | EP0636020B1 A pharmaceutical carrier system containing defined lipids |
| 05/12/1999 | EP0627900B1 Use of injectable collagen biomaterials for the repair and augmentation of the anal sphincters |
| 05/12/1999 | EP0525199B1 Composition containing ultrafine particles of magnetic metal oxide |
| 05/12/1999 | EP0444081B1 Pharmaceutical preparation |
| 05/12/1999 | DE19749413A1 Neuartige Sophoroselipide, Verfahren zu deren Herstellung und Verwendung Sophoroselipids novel, processes for their preparation and use |
| 05/12/1999 | CN1216472A A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 05/12/1999 | CN1216471A Stabilized antihepatitis-B vaccine tablets |
| 05/12/1999 | CN1216467A Immediate release PH-independent solid dosage form of cisapride |
| 05/12/1999 | CN1216466A Polyol composition |
| 05/12/1999 | CN1216465A Sustained release ionic conjugate |
| 05/11/1999 | US5902844 Solubilizing at least one water-soluble polymer and at least one amino acid-based containing component having a high molecular weight in an aqueous solvent to form a solubilized mixture; separating the aqueous solvent, spray drying |
| 05/11/1999 | US5902802 Cationic amphiphiles |
| 05/11/1999 | US5902798 Method of promoting dermal wound healing with chitosan and heparin or heparin sulfate |
| 05/11/1999 | US5902789 Intranasally administering composition consisting of insulin, polysorbate-80, nonoxynol-9; reduced nasal irritation |
| 05/11/1999 | US5902607 Controlled release drug delivery; receptor site of lectin macromolecule reversibly binding to carbohydrate and activated in response to levels of free carbohydrate groups to effect ungelation and release of drug |
| 05/11/1999 | US5902606 Solid and liquid solutions of sparingly water-soluble medicinal substances |
| 05/11/1999 | US5902602 Estradiol-TTS having water-binding additives |
| 05/11/1999 | US5902599 Biodegradable polymer networks for use in orthopedic and dental applications |
| 05/11/1999 | US5902593 Topically applied personal lubricant containing benzalkonium chloride as the active ingredient |
| 05/11/1999 | US5902590 Cosmetic and/or pharmaceutical formulations |